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ABSTRACT
Recent researches have expanded the concept that inflammation is a critical component of human diseases. The possible
mechanisms by which inflammation contribute to various conditions include increase of reactive species and inflammatory
cytokines and growth factors leading to alteration of biomolecules, induction of genetic change, cellular dysfunction and
enhancement of transformation or proliferation. Thus, targeting the inflammation is potential strategy for prevention of chronic
diseases. Numerous epidemiological and laboratory studies suggest that polymethoxyflavones (PMFs) exhibit a broad spectrum
of biological activities. Recently, we isolated and identified hydroxylated PMFs from citrus peels and have investigated their
biological activities, including anti-inflammation and cancer chemopreventive property. We suggest that hydroxylated PMFs
possess greater biological activity potency for chemoprevention on targeting inflammation.
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NATURAL OCCURRENCE AND CHEMISTRY
OF POLYMETHOXYFLAVONES
Citrus production worldwide in major citrus producing countries in 2007 was 115.7 million metric tons. Total
citrus production in the United States was 10.0 million
metric tons (National Agricultural Statistics Service).
Around 34% of these products were used for juice production(1), yielding approximately 44% (4 - 5 billion lbs
in the USA) of peels as by-products.
Medicinally, orange peel has been used in traditional
medicine in some Asian countries for relieving stomach
upset, skin inflammation and muscle pain. Flavonoids,
consisting of mainly polymethoxyflavones (PMFs), terpenoids, such as limonene and linalool, and other volatile
oils are the major ingredients of orange peel.
PMFs exist almost exclusively in Citrus genus, particularly in the peels of two citrus species, sweet orange
(C. sinensis) and mandarin (Citrus reticulata Blanco).
So far, about 30 PMFs have been isolated and identified
from different tissues of the citrus plants(1,2). The types
and content of PMFs vary between different varieties of
citrus species.
The structures of PMFs usually differ in the numbers,
types or positions of substitution on the 2-phenyl-γpyrone skeleton. The general structures of PMFs are
illustrated in Figure 1. Interestingly, the majority of the
identified compounds are derivatives from the base
structure of flavones, though two flavanones were
∗

identified from Dancy tangerine leaves(3). Among those
identified PMFs, tangeretin and nobiletin have been
intensively studied because of their relatively ready
availability and pharmacological properties.

Figure 1. General structure of polymethoxyflavones (PMFs).

Recently, several 5-demethylated PMFs such as
5-demethylnobiletin, 5-demethyltangeretin, 5-hydroxy3,6,7,8,3′,4′-hexamethoxyflavone have been characterized
in aged or long time storage orange peel and have led to a
new research field because of their greater potency and
better efficacy in biological activities than their PMF
counterparts(4,5).

THE ROLE OF INFLAMMATION IN HUMAN
DISEASES
Extensive research within past few decades has
revealed the linked between inflammation and human
diseases, including neurological diseases, cardiovascular
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diseases, obesity, metabolic disorders, bone and skeletal
diseases, cancers and aging(6,7). In normal condition,
inflammation is a defense and protective mechanism that
responses to tissue injury, bacteria infection, irradiation
and wounding. Migration of immune cells is immediately
occurred surrounding affected area. Inflammation
triggering is initiated by the recognition of pathogen by
immune cells of innate immune system(8). These immune
cells produce and release a series of mediators to amplify
inflammatory signals, and consequently recruitment of
inflammatory cells. Subsequently, recruited inflammatory
cells release reactive oxygen species (ROS), reactive
nitrogen species (RNS) and proinflammatory cytokines to
eliminate foreign bacteria and repair damaged tissue, and
finally restoration of homeostasis that coordinate restitute
by different cell types(8,9). This inflammatory process is
rapid and self-limiting that resolves by removal of
inflammatory cells through programmed cell death or
apoptosis. In general, inflammation is helpful to host
defense and health. However, aberrant regulation and
prolonged inflammation has found to contribute to the
development of chronic inflammatory conditions(10).
It has been known that chronic inflammation is a
critical driver of human diseases. Although chronic
inflammation is not the major cause of disease but
contributes to their pathogenesis. Serious tissue damage is
a hallmark of chronic inflammation caused by
over-activation of immune system, inefficient regulation
and prolonged inflammatory state. During chronic
inflammatory response, infiltrated immune and
inflammatory cells produce a wide variety of free radicals,
ROS and RNS including O2-• (superoxide anion), •OH
(hydroxyl radical), H2O2 (hydrogen peroxide) and nitric
oxide (NO) that react chemically with diverse
biomolecules, result in the function loss of genes, proteins,
enzymes, and plasma membrane, ultimately cellular
toxicity in surrounding tissues(7). In addition,
inflammatory signals also trigger a number of signaling
cascades, gene expression and activation of enzymes in
immune or inflammatory cells which in turn promote
generation of various oxidants and proinflammatory
molecules involved in expand tissue inflammation(7,9).
In cardiovascular disease, leucocytes adhesion and
increase of oxidative stress damage endothelia cells,
leading to dysfunction of vascular endothelium.
Macrophage plays a pivotal role in pathogenesis of
atherosclerosis. In early stage of atherosclerosis,
increased adhesive property between monocyte and
vascular endothelial cells through expression of adhesion
molecules results in monocyte transmigrating into arterial
intima and differentiating to macrophages, which uptake
oxidized-LDL (oxLDL) to generate foam cells, and
finally the formation of fatty streak(11). This multiple
process is triggered by different adhesion molecules,
inflammatory cytokines, chemoattractant molecules and
growth factor, including selectins, vascular cell adhesion
molecule-1 (VCAM-1), interleukins (ILs), tumor necrosis

ICoFF論文集.indd 338

Journal of Food and Drug Analysis, Vol. 20, Suppl. 1, 2012

factor-α (TNF-α), monocyte chemoattractant protein-1
(MCP-1) and platelet-derived growth factor (PDGF)(6,11).
Activation of microglial and astrocytes, both immune
cells in brain and central nervous system are the major
cause of neurodegenerative diseases such as Alzheimer’s
disease and Parkinson’s disease(12). Aggregated peptide
(amyloid β peptide) and protein (α-synuclein protein)
trigger activation of microglial and astrocytes that cause
neuronal damage or neurotoxicity through up-regulation
of ROS and various proinflammatory mediators including
NO, prostaglandin E2 (PGE2), ILs and TNF-α. These
inflammatory mediators produced by microglial and
astrocytes also activate each other to amplify
inflammatory state in neurons and promote
neuropathology(6,12).
Obesity is a chronic inflammatory disorder supported
by release of TNF-α and ILs from adipocyte that
influences the function of fat tissue and recruitment of
immune and inflammatory cells in adipose tissue, results
in creation of a chronic low-grade inflammation by
changing the morphology and composition of adipose
tissue(13). Increased TNF-α impairs insulin/IGF signaling
and decrease of glucose uptake and expression of GLUT4
that leads to insulin resistance, which is a characteristic in
most metabolic syndrome(13,14). In osteoporosis,
dysregulated inflammation from recruitment of immune
cells produces excessive proinflammatory cytokines
causing activation and differentiation of osteoclast, and
decreases osteoblastogenesis that impairs bone
remodeling(15).
Recently, numerous studies have indicated
inflammation is one of major risk factors for aging and
age-related diseases(16). Although the detailed mechanism
of inflammation and aging has not been understood, some
hypotheses are proposed. During aging, the imbalance of
redox status resulted from increased oxidative stress is
crucial in regulation of inflammatory mediators
expression, such as IL-1β, IL-6, TNF-α, inducible nitric
oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and
lipooxygenase (LPO). Elevated levels of inflammatory
cytokines are found in elderly people and patients with
age-related diseases(17). Activated pro-inflammatory
signaling in aging is regulated by complicated mechanism
including protein tyrosine kinase (PTK), mitogen
activated protein kinases (MAPKs) and nuclear factor-κB
(NF-κB). It has been accepted that age-related oxidative
stress-induced redox imbalance leading to systemic
inflammation and contributes to pathogenesis of
age-related diseases(16).
Growing evidences demonstrate that inflammation is
a one of the hallmarker of cancer development. Early in
18th century, Virchow observed that cancers are
frequently occurred at sites of chronic irritation(18).
Nowadays, numbers of evidence strongly supports that
the notion of inflammation plays a central role in
tumorigenesis of various cancers(19). Inflammation is
involved in every stage of cancer development, including
initiation, promotion and progression. In response to
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inflammatory stimulation, inflammatory cells are
recruited in injury tissue and produce excessive reactive
species (ROS and RNS) and pro-inflammatory cytokines
to against infection. However, elevated ROS, RNS and
cytokines also cause damage of normal tissue. Once
surviving, the injured cells with genetic change, termed as
initiated cells, tend toward proliferate and transform to
malignant cells. As tumor tissue formation, cancer cells
also produce chemokines to attract inflammatory cells
and stromal cells, creating an inflammatory
microenvironment that functions to support nutrition,
growth factors and cytokines, and finally facilitate tumor
growth and development. A lot of molecules are involved
in inflammation-medicated tumorigenesis, including
transcription factors (NF-κB and STAT3), inflammatory
cytokines and enzymes (iNOS, COX-2, ILs, TNF-α),
angiogenenic factor (HIF-1a and VEGF) as well as
multiple upstream signaling pathways (PKC, MAPKs,
PI3K/Akt)(6,19).

ANTI-INFLAMMATORY ACTIVITY OF
POLYMETHOXYLFLAVONES
Numbers of studies suggest that PMFs in citrus peel
exhibit a broad spectrum of biological activity, including
anti-inflammatory, anti-carcinogenic, and anti-atherogenic properties. Previously, different hydroxylated PMFs
and PMFs have been isolated from sweet orange (Citrus
sinensis) peel(4). We found 5-hydroxy-6,7,8,3′,4′-pentamethoxyflavone and 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone (5-OH-HxMF) demonstrated potent antiproliferative activity through the induction of apoptosis in
human leukemia cancer cells(4). Moreover, 5-OH-HxMF
treatment resulted in ROS production, triggered apoptosis
signaling through mitochondria cytochrome c release and
caspases cascade(5).
As mentioned before, inflammation is associated
with the development of cancer(6,19). Therefore, we
investigated the anti-inflammatory property of
5-OH-HxMF by using in vivo mouse skin model. The
mouse skin model has been extensively used to study
multistep tumorigenesis and the molecular mechanisms.
In this model, the characteristic of initiation stage is
genetic damage in the formation of DNA adducts or
initiator-induced DNA base changes, such as
7,12-dimethyl-benzanthracene (DMBA). The promotion
stage of mouse skin carcinogenesis involves the
production and maintenance of a chronic state of
hyperplasia and cell proliferation and ultimately the
selective clonal expansion of initiated cells. The classical
skin tumor promoter is tetradecanoylphorbol-13-acetate
(TPA), and is known to up-regulation of arachidonic acid
cascade and ornithine decarboxylase (ODC) in mouse
epidermis. Indeed, TPA treatment induces a reaction
similar to the inflammatory wound reaction by enhancing
the expression of a wide variety of proinflammatory
mediators and growth factors that leading to recruit
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inflammatory cells and promote tumor cell
proliferation(20). In our study, we found that topical
application of TPA in mouse skin caused leukocytes
infiltration and epidermal proliferation. Pre-treatment
with 5-OH-HxMF (1 and 3 mol) resulted in significantly
inhibited TPA-induced mouse skin inflammation by
decreasing inflammatory parameters(21). At molecular
levels, pre-treatment with 5-OH-HxMF reduced
TPA-induced both inducible nitric oxide synthase (iNOS)
and cyclooxygenase-2 (COX-2) protein expression
through interfering with MAPKs, PI3K/Akt and PKC
signaling, leading to blocking the activation of
transcription factors (NF-κB and STAT3). Furthermore,
5-OH-HxMF significantly inhibited DMBA/TPA-induced
skin tumor formation by reducing the tumor incidence
and tumor multiplicity of papillomas at 20 weeks(21). By
measurement of the diameters of skin tumors, we also
found the tumor size in 5-OH-HxMF treated group tended
to be smaller than that of untreated group, which might
contribute to decreased iNOS, COX-2 and VEGF protein
levels.
Nobiletin is a major PMF in citrus fruits (particularly
in the peel). Both in vitro and in vivo data have shown
that nobiletin has anti-inflammatory and anti-carcinogenic
activities. The biotransformation study of nobiletin has
shown that it undergoes demethylation pathway with the
formation of mono-demethylated nobiletin as major
metabolites. We have identified two known nobiletin
metabolites in mouse urine, 3′-demethylnobiletin and
4′-demethylnobiletin as well as a novel one,
3′,4′-didemethylnobiletin (DDMN)(22). In lipopolysaccharide
(LPS)-stimulated macrophage, co-treatment with three
metabolites all markedly reduced LPS-induced nitrite
production. Among them, DDMN significantly inhibited
both iNOS and COX-2 gene expression in LPSstimulated RAW264.7 macrophage. Furthermore, we
compared the anti-inflammatory activity of nobiletin and
its metabolite DDMN in mouse skin. Our data showed
that application of DDMN before TPA treatment afforded
significant inhibition of TPA-induced iNOS, COX-2 and
ODC expression in a dose-dependent manner(23). DDMN
inhibited TPA-induced DNA-binding activity of NF-κB
and AP-1 by suppressing phosphorylation of IκBαand
p65 and subsequent nuclear translocation of p50 and
p65/RelA subunits of NF-κB and PKC activity. More
importantly, DDMN showed markedly more strong
anti-tumor promoting effect than nobiletin according to
the reduced tumor number(23). Taken together, above
results demonstrated that the metabolite, DDMN, possess
more potent anti-inflammatory activity than its parent
compound.
Colorectal cancer (CRC) is one of major causes of
cancer-related mortality in both men and women
worldwide. Inflammation plays a major role in pathology
of colon cancer(24). Pervious studies showed that feeding
nobiletin
reduced
carcinogen
azoxymethane
(AOM)-induced aberrant crypt foci (ACF) formation in
rats(25). More recently, we found the potent inhibitory
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effects of 5-hydroxy PMFs (5-hydroxy-6,7,8,3',4'-pentamethoxyflavone, 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone, and 5-hydroxy-6,7,8,4'-tetramethoxyflavone)
compared to their permethoxylated counterparts on
human colon cancer HCT116 and HT29 cells(26). In
addition, dietary hydroxylated PMFs (0.01 and 0.05%)
strongly reduced numbers of large aberrant crypt foci (≧
6 ACF) and tumors in colonic tissue in male ICR mice(27).
Dietary
hydroxylated
PMFs
interfered
with
Wnt/β-catenin and epidermal growth factor receptor
(EGFR)/Ras/MAPKs pathways, blocked activation of
NF-κB and STAT3 that consequently decreased the
expression of iNOS, COX-2, cyclin D1 and VEGF,
resulting in suppression of colonic tumorigenesis(27).
Overall, these evidences suggested that hydroxylated
PMFs have great potential as a novel chemopreventive
agent to be used in the treatment of inflammation
associated with tumorigenesis.
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